Company Name: |
Eastbang Pharmaceuticals Technology Co., Ltd.
|
Tel: |
+86 (20) 28996708,29078958,28139708,29076128,28133708,28139728,28139738,28133718,021-31663278,021-31663578,021-60538387 |
Email: |
|
Products Intro: |
Product Name:(S)-2-(3-((2-isopropylthiazol-4-yl)Methyl)-3-Methylureido)-4-Morpholinobutanoic acid CAS:1004316-92-0 Purity:98% 99% Package:1kg;25kg;100kg
|
Company Name: |
Lynnchem
|
Tel: |
86-(0)29-85992781 17792393971 |
Email: |
info@lynnchem.com |
Products Intro: |
Product Name:(S)-2-(3-((2-isopropylthiazol-4-yl)Methyl)-3-Methylureido)-4-Morpholinobutanoic acid CAS:1004316-92-0 Purity:98% Package:100mg;1g
|
|
| (S)-2-(3-((2-isopropylthiazol-4-yl)Methyl)-3-Methylureido)-4-Morpholinobutanoic acid Basic information |
Product Name: | (S)-2-(3-((2-isopropylthiazol-4-yl)Methyl)-3-Methylureido)-4-Morpholinobutanoic acid | Synonyms: | (S)-2-(3-((2-isopropylthiazol-4-yl)Methyl)-3-Methylureido)-4-Morpholinobutanoic acid;(alphaS)-alpha-[[[Methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-4-morpholinebutanoic acid;4-Morpholinebutanoic acid, α-[[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]amino]-, (αS)-;Cobicistat Impurity 14;(ALPHAS)-ALPHA-[[[METHYL[[2-(1-METHYLETHYL)-4-THIAZOLYL]METHYL]AMINO]CARBONYL]AMINO]-4-MORPHOLINEBUTANOIC ACID 1004316-92-0;(2S)-2-{[Methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}-4-(morpholin-4-yl)butanoic Acid | CAS: | 1004316-92-0 | MF: | C17H28N4O4S | MW: | 384.49 | EINECS: | | Product Categories: | | Mol File: | 1004316-92-0.mol | |
| (S)-2-(3-((2-isopropylthiazol-4-yl)Methyl)-3-Methylureido)-4-Morpholinobutanoic acid Chemical Properties |
Boiling point | 640.0±55.0 °C(Predicted) | density | 1.238±0.06 g/cm3(Predicted) | pka | 3.98±0.10(Predicted) |
| (S)-2-(3-((2-isopropylthiazol-4-yl)Methyl)-3-Methylureido)-4-Morpholinobutanoic acid Usage And Synthesis |
Uses | (2S)-2-{[Methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}-4-(morpholin-4-yl)butanoic Acid is an impurity of Cobicistat (C633150), a HIV protease inhibitor that has been coadministered with low-dose ritonavir (R535000) as a pharmacoenhancer. |
| (S)-2-(3-((2-isopropylthiazol-4-yl)Methyl)-3-Methylureido)-4-Morpholinobutanoic acid Preparation Products And Raw materials |
|